BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 28217292)

  • 21. Does normobaric hyperoxia increase oxidative stress in acute ischemic stroke? A critical review of the literature.
    Weaver J; Liu KJ
    Med Gas Res; 2015; 5():11. PubMed ID: 26306184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood-Brain Barrier Protection as a Therapeutic Strategy for Acute Ischemic Stroke.
    Sifat AE; Vaidya B; Abbruscato TJ
    AAPS J; 2017 Jul; 19(4):957-972. PubMed ID: 28484963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mild hypothermia reduces tissue plasminogen activator-related hemorrhage and blood brain barrier disruption after experimental stroke.
    Tang XN; Liu L; Koike MA; Yenari MA
    Ther Hypothermia Temp Manag; 2013 Jun; 3(2):74-83. PubMed ID: 23781399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of tissue plasminogen activator on cerebral microvessels of rats during focal cerebral ischemia and reperfusion.
    Yang DY; Pan HC; Chen CJ; Cheng FC; Wang YC
    Neurol Res; 2007 Apr; 29(3):274-82. PubMed ID: 17509227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Co-administration of tissue plasminogen activator and hyperbaric oxygen in ischemic stroke: a continued promise for neuroprotection.
    Yang ZS; Mu J
    Med Gas Res; 2017; 7(1):68-73. PubMed ID: 28480034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IMM-H004 prevents toxicity induced by delayed treatment of tPA in a rat model of focal cerebral ischemia involving PKA-and PI3K-dependent Akt activation.
    Zuo W; Chen J; Zhang S; Tang J; Liu H; Zhang D; Chen N
    Eur J Neurosci; 2014 Jun; 39(12):2107-18. PubMed ID: 24649933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preclinical Validation of the Therapeutic Potential of Glasgow Oxygen Level Dependent (GOLD) Technology: a Theranostic for Acute Stroke.
    Deuchar GA; van Kralingen JC; Work LM; Santosh C; Muir KW; McCabe C; Macrae IM
    Transl Stroke Res; 2019 Oct; 10(5):583-595. PubMed ID: 30506268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recombinant ADAMTS13 reduces tissue plasminogen activator-induced hemorrhage after stroke in mice.
    Wang L; Fan W; Cai P; Fan M; Zhu X; Dai Y; Sun C; Cheng Y; Zheng P; Zhao BQ
    Ann Neurol; 2013 Feb; 73(2):189-98. PubMed ID: 23280993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination approaches to attenuate hemorrhagic transformation after tPA thrombolytic therapy in patients with poststroke hyperglycemia/diabetes.
    Fan X; Jiang Y; Yu Z; Yuan J; Sun X; Xiang S; Lo EH; Wang X
    Adv Pharmacol; 2014; 71():391-410. PubMed ID: 25307224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination therapy for ischemic stroke: Novel approaches to lengthen therapeutic window of tissue plasminogen activator.
    Knecht T; Borlongan C; Dela Peña I
    Brain Circ; 2018; 4(3):99-108. PubMed ID: 30450415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NURR1 involvement in recombinant tissue-type plasminogen activator treatment complications after ischemic stroke.
    Merino-Zamorano C; Hernández-Guillamon M; Jullienne A; Le Béhot A; Bardou I; Parés M; Fernández-Cadenas I; Giralt D; Carrera C; Ribó M; Vivien D; Ali C; Rosell A; Montaner J
    Stroke; 2015 Feb; 46(2):477-84. PubMed ID: 25503547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current progress in searching for clinically useful biomarkers of blood-brain barrier damage following cerebral ischemia.
    Li W; Pan R; Qi Z; Liu KJ
    Brain Circ; 2018; 4(4):145-152. PubMed ID: 30693340
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Very Mild Hypothermia (35°C) Postischemia Reduces Infarct Volume and Blood/Brain Barrier Breakdown Following tPA Treatment in the Mouse.
    Cechmanek BK; Tuor UI; Rushforth D; Barber PA
    Ther Hypothermia Temp Manag; 2015 Dec; 5(4):203-8. PubMed ID: 26075540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined tissue plasminogen activator and an NK1 tachykinin receptor antagonist: an effective treatment for reperfusion injury following acute ischemic stroke in rats.
    Turner RJ; Vink R
    Neuroscience; 2012 Sep; 220():1-10. PubMed ID: 22750240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperbaric oxygen increases tissue-plasminogen activator-induced thrombolysis
    Chazalviel L; Haelewyn B; Degoulet M; Blatteau JE; Vallée N; Risso JJ; Besnard S; Abraini JH
    Med Gas Res; 2016; 6(2):64-69. PubMed ID: 27867469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Normobaric hyperoxia extends the reperfusion window in focal cerebral ischemia.
    Kim HY; Singhal AB; Lo EH
    Ann Neurol; 2005 Apr; 57(4):571-5. PubMed ID: 15786465
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early outcome and blood-brain barrier integrity after co-administered thrombolysis and hyperbaric oxygenation in experimental stroke.
    Michalski D; Pelz J; Weise C; Kacza J; Boltze J; Grosche J; Kamprad M; Schneider D; Hobohm C; Härtig W
    Exp Transl Stroke Med; 2011 Jun; 3(1):5. PubMed ID: 21679435
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic hypothermia for acute ischemic stroke.
    Froehler MT; Ovbiagele B
    Expert Rev Cardiovasc Ther; 2010 Apr; 8(4):593-603. PubMed ID: 20397832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Normobaric oxygen treatment in acute ischemic stroke: a clinical perspective.
    Shi SH; Qi ZF; Luo YM; Ji XM; Liu KJ
    Med Gas Res; 2016; 6(3):147-153. PubMed ID: 27867482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of tissue plasminogen activator in acute ischemic stroke.
    Hatcher MA; Starr JA
    Ann Pharmacother; 2011 Mar; 45(3):364-71. PubMed ID: 21386027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.